Yale VAMOS Program Provides Holistic Vascular Care
The Vascular Medicine OutcomeS (VAMOS) program at Yale University, an integral program supported by the Yale New Haven Health’s Heart and Vascular Center and Center for Musculoskeletal Care, includes a global team of interventional cardiologists, vascular surgeons, podiatrists, radiologists, allied health professionals, and outcomes researchers committed to transforming how PAD is diagnosed and treated, and how patients access care.
Eric Brandt selected for ACC young investigator award
Eric J. Brandt MD, a postdoctoral fellow at Yale Cardiovascular Medicine, was selected as a finalist for the American College of Cardiology (ACC) Young Investigator Award. He will present his research at the annual Scientific Session March 29.
Anti-COVID-19 Medications, While Possibly Life Saving, Can Have Life Threatening Complications if Used Inappropriately
The heightened awareness around the anti-malaria drug hydroxychloroquine as well as other experimental treatments for COVID-19 has led to reports of risky behaviors, according to Yale School of Medicine physicians.
A redefining moment for heart failure
At Yale, Drs. Nihar Desai and Tariq Ahmad help some of the most medically vulnerable patients — those with heart failure. An important part of that work, they said, is pointing out the need to update common classifications of heart failure now used by the medical profession.
Heart Disease in Women: How Pregnancy, Menopause, and Other Factors Affect Risk
Current paradigms about heart attacks were, until recently, primarily based on men. Doctors are now learning how different heart attacks and heart disease can be in men and women. "We know now that when something is not right in a woman, the first line of testing may not reveal the answer," says Yale Medicine cardiologist Erica Spatz, MD.Source: Yale Medicine
High-tech Pump May Increase Risk of Death and Bleeding, Study Finds
A new national study finds that the use of the Impella circulatory support device is associated with higher rates of death and major bleeding among patients with acute myocardial infarction and cardiogenic shock who are implanted with mechanical circulatory support devices.